Dashboard
Manage Tickers

NTLAIntellia Therapeutics, Inc.

Nasdaq intelliatx.com


$ 23.99 $ -1.00 (-4 %)    

Tuesday, 25-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 24
$ 24.84
$ 0.00 x 0
$ 0.00 x 0
$ 23.98 - $ 24.84
$ 19.37 - $ 46.50
1,664,635
na
2.29B
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 03-14-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 06-03-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Intellia Therapeutics Presents Data On Red...
06/25/2024 19:32:54

First-ever clinical data demonstrating redosing with an investigational in vivo CRISPR-based therapyFollow-on dosing with a 55 ...

cantor-fitzgerald-reiterates-overweight-on-intellia-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/24/2024 18:30:10

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

unveiling-6-analyst-insights-on-intellia-therapeutics
Unveiling 6 Analyst Insights On Intellia T...
06/24/2024 18:01:29

truist-securities-maintains-buy-on-intellia-therapeutics-maintains-120-price-target
Truist Securities Maintains Buy on Intelli...
06/24/2024 17:34:40

Truist Securities analyst Joon Lee maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and maintains $120 price target.

rxo-alnylam-pharmaceuticals-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
RXO, Alnylam Pharmaceuticals And Other Big...
06/24/2024 11:54:53

5-biotech-stocks-with-key-catalysts-this-week-merck-intellia-verona-and-more
5 Biotech Stocks With Key Catalysts This W...
06/24/2024 08:51:47

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

cantor-fitzgerald-reiterates-overweight-on-intellia-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:12:26

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

intellia-therapeutics-announced-the-acceptance-of-an-abstract-featuring-redosing-data-from-the-phase-1-study-of-ntla-2001-has-been-selected-for-an-oral-presentation-at-the-peripheral-nerve-society-annual-meeting
Intellia Therapeutics Announced The Accept...
06/17/2024 11:33:16

NTLA-2001 is an investigational in vivo CRISPR-based gene editing therapy designed to be a single-dose treatment for transthyre...

avidity-biosciences-and-cleanspark-were-among-the-10-biggest-mid-cap-stock-gainers-last-week-june-9-june-15-are-these-in-your-portfolio
Avidity Biosciences And CleanSpark Were Am...
06/16/2024 18:25:10

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, Cle...

cathie-wood-lead-ark-invest-dumps-76m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-choppiness
Cathie Wood-Lead Ark Invest Dumps $7.6M Wo...
06/11/2024 02:28:34

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). ...

cathie-wood-led-ark-invest-buys-99m-worth-of-amazon-shares-also-picks-up-reddit-stock
Cathie Wood-Led Ark Invest Buys $9.9M Wort...
06/07/2024 02:25:44

cracking-the-code-understanding-analyst-reviews-for-intellia-therapeutics
Cracking The Code: Understanding Analyst R...
06/04/2024 20:00:55

cantor-fitzgerald-reiterates-overweight-on-intellia-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/04/2024 17:28:53

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

why-intellia-therapeutics-shares-are-trading-higher-monday
Why Intellia Therapeutics Shares Are Tradi...
06/03/2024 15:33:43

Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hered...

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

Core News & Articles
Market-Moving News for June 3rd
06/03/2024 12:35:14

GME: 103% | 'Roaring Kitty' Reveals Massive GME Position On Reddit, Including $65M Call Options: Is He Bringing 'Co...

intellia-therapeutics-announced-single-dose-of-ntla-2002-led-to-a-98-mean-reduction-in-monthly-hereditary-angioedema-attack-rate-with-an-average-follow-up-of-over-20-months-across-all-patients
Intellia Therapeutics Announced Single Dos...
06/02/2024 14:38:47

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on revolutionizing medicine ...

cathie-wood-led-ark-invest-sells-nearly-28m-worth-of-robinhood-shares-amid-crypto-api-launch-and-lackluster-bitcoin-price-action
Cathie Wood-Led Ark Invest Sells Nearly $2...
05/31/2024 03:38:32

On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhoo...

cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf
Cathie Wood's Ark Innovation ETF Sees Shar...
05/28/2024 11:29:37

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

citigroup-maintains-neutral-on-intellia-therapeutics-lowers-price-target-to-29
Citigroup Maintains Neutral on Intellia Th...
05/10/2024 21:34:12

Citigroup analyst David Lebowitz maintains Intellia Therapeutics (NASDAQ:NTLA) with a Neutral and lowers the price target fr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)